Antihyperlipidemic Drugs Market: A Comprehensive Analysis
The global antihyperlipidemic drugs market size was valued at USD 12.91 billion in 2023, driven by the increasing prevalence of coronary heart diseases, lipid disorders, and hyperlipidemia cases globally. The market is expected to grow at a CAGR of 5.8% during the forecast period of 2024-2032, with the values likely to rise from...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek